Valuation: Evogene Ltd.

Market Cap 60.21L 0 51.58L 48.26L 44.17L 82.9L 58Cr 84L 5.7Cr 2.22Cr 29Cr 2.26Cr 2.21Cr 96Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 60.21L 0 51.58L 48.26L 44.17L 82.9L 58Cr 84L 5.7Cr 2.22Cr 29Cr 2.26Cr 2.21Cr 96Cr EV / Sales 2026 *
4.06x
EV / Sales 2027 * 2.32x
Free-Float
72.15%
Yield 2026 *
-
Yield 2027 * -
1 day-3.45%
1 week-8.84%
Current month+11.45%
1 month-4.62%
3 months-17.00%
6 months-36.82%
Current year-42.35%
1 week 165.1
Extreme 165.1
191
1 month 143.6
Extreme 143.6
229.8
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
478.7
3 years 115.1
Extreme 115.1
3,700
5 years 115.1
Extreme 115.1
10,430
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 01/12/2004
Corporate Officer/Principal - -
Corporate Officer/Principal - 01/01/2022
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 03/06/2010
Chairman 60 01/06/2021
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Buy

Director

4,60,000 2.9111%
04/08/26 Buy

Director

8,00,000 5.0628%
18/03/26 Other

Executive/Senior Manager

40,000 0.4588%
Change 5-day change 1-year change 3-year change Capi.($)
-3.45%-8.84%-58.77%-93.48% 62.36L
+1.09%+3.39%+3.50%+25.49% 5.12TCr
-1.07%+3.69%+479.26%+607.16% 4.54TCr
+1.44%+5.19%+21.06%+93.98% 4.2TCr
+1.47%+7.58%+35.29%+21.42% 4.21TCr
-0.93%-4.80%+17.39%+46.60% 3.19TCr
-0.60%+2.87% - - 1.67TCr
+1.32%+6.67%+33.29%+148.62% 1.71TCr
+0.03%+3.91%+5.84%+35.04% 1.48TCr
+1.28%+4.95%+84.98%+48.41% 1.39TCr
Average +0.05%+2.31%+69.09%+103.69% 2.75TCr
Weighted average by Cap. +0.46%+3.13%+103.28%+150.62%

Financials

2026 *2027 *
Net sales 14.84L 0 12.71L 11.89L 10.89L 20.43L 14Cr 20.7L 1.41Cr 54.8L 7.13Cr 55.72L 54.51L 24Cr 26L 0 22.27L 20.84L 19.08L 35.8L 25Cr 36.27L 2.46Cr 96.01L 12Cr 97.63L 95.5L 41Cr
Net income -1.67Cr -0 -1.43Cr -1.34Cr -1.22Cr -2.3Cr -159.66Cr -2.33Cr -16Cr -6.16Cr -80Cr -6.27Cr -6.13Cr -265.28Cr -1.39Cr -0 -1.19Cr -1.12Cr -1.02Cr -1.92Cr -133.14Cr -1.94Cr -13Cr -5.14Cr -67Cr -5.22Cr -5.11Cr -221.22Cr
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
52
Date Price Change Volume
21/26/21 ILA 173.30 -3.45% 32,101
20/26/20 ILA 179.50 +4.06% 62,975
19/26/19 ILA 172.50 +1.59% 39,678
18/26/18 ILA 169.80 -5.14% 72,446
17/26/17 ILA 179.00 -6.28% 1,32,191

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock